Preferred Label : ioxitalamic acid;

MeSH note : RN given refers to parent cpd; Telebrix 38 contains both sodium ioxitalamate & meglumine ioxitalamate; structure;

MeSH synonym : 5-acetamido-N-(2- hydroxyethyl)-2,4,6-triiodoisophthalamic acid;

MeSH hyponym : sodium ioxithalamate;

MeSH CAS label : 3-(acetylamino)-5-(((2-hydroxyethyl)amino)carbonyl)- 2,4,6-triiodobenzoic acid;

MeSH Related Number : ioxitalamic acid, sodium salt; 28179-44-4 (ioxitalamic acid); 33954-26-6 (Na salt); 33954-26-6 (ioxitalamic acid, sodium salt); 8P8Y8ZXJ8Y;

Registry Number MeSH : 28179-44-4;

Related CAS MeSH : 33954-26-6 (ioxitalamic acid, sodium salt);

related registry number list (CISMeF) : 33954-26-6 (Na salt);

CISMeF hyponym : ioxitalamate; acide ioxitalamique sel de Na;

Codes EINECS : 248-887-5;

Is substance : O;

UNII : 967RDI7Z6K;

InChIKey : OLAOYPRJVHUHCF-UHFFFAOYSA-N;

Details


Main resources

You can consult :


https://www.has-sante.fr/portail/jcms/c_2854452/fr/telebrix-12-sodium-telebrix-30-meglumine
2018
false
false
false
false
France
French
evaluation of the transparency committee
ioxitalamic acid, sodium salt
insurance, health, reimbursement
ioxitalamic acid
meglumine ioxithalamate
iothalamic acid
iothalamate meglumine

---
http://www.has-sante.fr/portail/jcms/c_1621549/fr/telebrix-12-sodium
http://www.has-sante.fr/portail/jcms/c_1621548/fr/telebrix-12-sodium-avis-ct11814
http://www.has-sante.fr/portail/display.jsp?id=c_474606
2013
France
French
evaluation of the transparency committee
administration, intravesical
ioxitalamic acid, sodium salt
ioxitalamic acid
iothalamic acid
contrast media
insurance, health, reimbursement
ioxitalamic acid
urinary bladder

---
http://www.has-sante.fr/portail/jcms/c_1621564/fr/telebrix-35
http://www.has-sante.fr/portail/jcms/c_1621563/fr/telebrix-35-avis-ct12692
http://www.has-sante.fr/portail/jcms/c_474614/fr/telebrix-35
http://www.has-sante.fr/portail/jcms/c_399071/fr/telebrix-35-solution-injectable-flacon-de-100-ml-boite-de-1-flacon-de-50-ml-avec-seringue-et-microperfuseur-boite-de-1
2013
France
French
evaluation of the transparency committee
insurance, health, reimbursement
drug combinations
contrast media
ioxitalamic acid
meglumine ioxithalamate
ioxitalamic acid, sodium salt
ioxitalamic acid
Outcome Assessment, Health Care
injections
urography
tomography, X-ray computed
angiocardiography
coronary angiography
angiography
iothalamate meglumine
iothalamic acid

---
Nous contacter.
16/06/2024


[Home] [Top]

© Rouen University Hospital. Any partial or total use of this material must mention the source.